Teva Sues FDA Over New Stance On Generic-Drug Exclusivity

Teva Sues FDA Over New Stance On Generic-Drug Exclusivity

By Jeff Overley Law360 (October 18, 2018, 9:55 PM EDT) — A new U.S. Food and Drug Administration policy threatens to deprive generic-drug makers of lucrative exclusivity even when they expose themselves to litigation by challenging patents for brand-name drugs, Teva Pharmaceuticals… To view the full article, register now. Source link

Pharmacists Will Now Be Able to Help You Save Money on Prescriptions

Pharmacists Will Now Be Able to Help You Save Money on Prescriptions

Congress has approved legislation that lifts a “gag rule” forbidding pharmacists from telling you when you can pay less for a prescription. Sometimes medications are cheaper if you pay cash instead of using your insurance. Getty Images There’s something your pharmacist has been meaning to tell you. In those talks about the goals of a […]

FDA Looks to Harmonize Generic Drug Scientific and Technical Standards via ICH

FDA Looks to Harmonize Generic Drug Scientific and Technical Standards via ICH

The US Food and Drug Administration (FDA) revealed Thursday that it’s offering a proposal to the International Council on Harmonisation (ICH) to better harmonize scientific and technical standards for generic drugs. The plan is to allow generic drug developers to implement a single global drug development program, with common elements of applications to file, to […]

Are Generic Drugs Actually the Same as Name Brand Ones?

Are Generic Drugs Actually the Same as Name Brand Ones?

Things that are simple when you’re healthy can feel nearly impossible when you’re sick — including trying to figure out which medicine you should buy to help you feel better. They all come in similar boxes and promise to do similar things, so why is this one $6 and that one $15? If you’re paying […]

20 Drugmakers Must Face Generic Price-Fixing MDL

20 Drugmakers Must Face Generic Price-Fixing MDL

By Dani Kass Law360 (October 17, 2018, 8:15 PM EDT) — A Pennsylvania federal court has greenlighted the first round of multidistrict litigation accusing more than 20 generic-drug makers of conspiring to fix their prices, excusing only Teligent Inc. from the antitrust… To view the full article, register now. Source link

Over 20 Drugmakers Must Face Generic Price-Fixing MDL

Over 20 Drugmakers Must Face Generic Price-Fixing MDL

By Dani Kass Law360 (October 17, 2018, 8:15 PM EDT) — A Pennsylvania federal court has greenlighted the first round of multidistrict litigation accusing more than 20 generic-drug makers of conspiring to fix their prices, excusing only Teligent Inc. from the antitrust… To view the full article, register now. Source link

If Hospitals Make Their Own Generics, Will Patients Benefit?

If Hospitals Make Their Own Generics, Will Patients Benefit?

A group of hospitals have joined together to make their own generic drugs in order to address rising prices and shortages. A group of hospitals have launched Civica Rx in order to produce cheaper generics. Getty Images Generic drugs are supposed to be a win-win for the healthcare system. They work essentially the same as […]

Generic drugmakers lose bid to dismiss price-fixing lawsuits

Generic drugmakers lose bid to dismiss price-fixing lawsuits

A federal judge has rejected motions by 20 drug companies including Mylan NV and Teva Pharmaceutical Industries Ltd to dismiss lawsuits accusing them of conspiring to raise the prices for six generic drugs including the common antibiotic doxycycline. U.S. District Judge Cynthia Rufe in Philadelphia on Tuesday ruled the proposed class actions brought on behalf […]

Can Allergan's Key Drugs, Solid Pipeline Abate Generic Woes?

Can Allergan's Key Drugs, Solid Pipeline Abate Generic Woes?

We issued an updated research report on Allergan plc (AGN – Free Report) on Oct 16. Allergan boasts dominant growth franchises across several therapeutic areas. Allergan’s key products like Botox, Juvéderm collection of fillers, Linzess and new products such as Viberzi and Vraylar are supporting sales amid ongoing exclusivity challenges for older products like Alzheimer’s […]